Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 19.00K | $ 6.10M | $ 150.00K | $ 833.00K | $ 189.00K |
Total Assets | $ 24.96M | $ 21.00M | $ 15.19M | $ 15.41M | $ 14.84M |
Total Debt | $ 4.13M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
Net Debt | $ 4.11M | $ -6.10M | $ -150.00K | $ -833.00K | $ -189.00K |
Total Liabilities | $ 6.29M | $ 372.00K | $ 778.00K | $ 548.00K | $ 1.51M |
Stockholders Equity | $ 18.68M | $ 20.63M | $ 14.41M | $ 14.87M | $ 13.32M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |